Stocks · Health care · Services-Commercial Physical & Biological Research

MAXCYTE, INC.

MXCT Clue Score24
United States Fiscal year ends December CIK 0001287098 Results filed 14 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
William W Brooke
13 Aug 2025
Director
Buy
50,000
$1.29
$64.50K
Richard Douglas
13 Aug 2025
Director
Buy
80,000
$1.39
$111.04K
Stanley C Erck
13 Aug 2025
Director
Buy
100,000
$1.37
$137.22K
Maher Masoud
13 Aug 2025
President and CEO
Buy
75,000
$1.37
$102.92K
Douglas J Swirsky
13 Aug 2025
Chief Financial Officer
Buy
50,000
$1.29
$64.50K
Maher Masoud
10 Jun 2024
President and CEO
Buy
70,443
$4.90
$345.24K
Maher Masoud
7 Jun 2024
President and CEO
Buy
29,557
$4.87
$143.82K
Richard Douglas
29 Mar 2023
Director
Buy
80,000
$4.32
$345.48K
Richard Douglas
22 Nov 2021
Director
Buy
20,000
$11.12
$222.40K
Casdin Partners Master Fund, L.P.
30 Jul 2021
10% owner
Buy
1,800,000
$13.00
$23.40M

What was left out

Form 4 filings counted 142
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 88
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 2,976,079
Sales filed before the plan box existed 2
History held since 3 Aug 2021